(Total Views: 50)
Posted On: 11/18/2024 11:59:44 AM
Post# of 26763
$UNCY Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update
– OLC New Drug Application (NDA) Accepted by the FDA with a PDUFA Target Action Date of June 28, 2025–
– Commercial Planning in Progress for 2025 Launch –
– Late Breaker Poster Presentation on OLC at ASN Kidney Week –
– Successful Completion of UNI-494 Phase 1 Trial –
https://finance.yahoo.com/news/unicycive-anno...00882.html
– OLC New Drug Application (NDA) Accepted by the FDA with a PDUFA Target Action Date of June 28, 2025–
– Commercial Planning in Progress for 2025 Launch –
– Late Breaker Poster Presentation on OLC at ASN Kidney Week –
– Successful Completion of UNI-494 Phase 1 Trial –
https://finance.yahoo.com/news/unicycive-anno...00882.html
(0)
(0)
Scroll down for more posts ▼
